m.Stock by Mirae AssetOpen Demat Account
m.Stock by Mirae Asset

IPOQ-Line Biotech Ltd IPO

  • Price Range

    ₹326 - ₹343

  • Min. Quantity

    800 Shares

  • Closes on

    May 25, 2026

  • Min. investment

    ₹2,74,400

Q-Line Biotech Ltd IPO Timeline

EventDate
Q-Line Biotech Ltd IPO Opening DateMay 21, 2026
Q-Line Biotech Ltd IPO Closing Date May 25, 2026
Basis of AllotmentMay 26, 2026
Initiation of RefundsMay 27, 2026
Credit of Shares to DematMay 27, 2026
Q-Line Biotech Ltd IPO Listing DateMay 29, 2026

Q-Line Biotech Ltd IPO Details

Q-Line Biotech Ltd IPO DateMay 21, 2026 to May 25, 2026
Q-Line Biotech Ltd IPO Face Value₹10 per share
Q-Line Biotech Ltd IPO Price₹326 to ₹343 per share
Q-Line Biotech Ltd IPO Lot Size800
Issue Size Shares of ₹10 (aggregating up to ₹214.48 Cr)
Fresh Issue Shares of ₹10 (aggregating up to ₹214.48 Cr)
Offer for Sale-
Issue TypeBook Building - SME
Listing At NSE - SME
QIB Shares OfferedNot more than 11,88,000 of the Net Offer
Retail Shares OfferedNot less than 20,79,200 of the Net Offer
NII (HNI) Shares OfferedNot less than 12,04,800 of the Net Offer
Company PromotersSaurabh Garg, Amita Garg, Ayush Garg

Q-Line Biotech Ltd IPO Lot Size

The Q-Line Biotech Ltd IPO lot size is 800 shares. A retail-individual investor can apply for up to 0 lots (0 shares or ₹0).

Application LotsSharesAmount
Minimum1800₹2,74,400
Maximum-0₹0
  • Risks
  • Opportunities
  • Established manufacturing capabilities with focus on R&D, Reverse Engineering and quality control.
  • Diversified product portfolio with focus on IVD industry.
  • Widespread distribution network with a presence across all four regions.
  • Long standing relationships with customers.
  • Track record of healthy financial performance.
  • Experienced Promoter and Management team.

Objects of the Issue

The company proposes to utilise the Net Proceeds from the Fresh Issue towards funding the following objects:

  • To meet Working Capital requirements
  • Repayment of certain borrowing availed by the Company, in part or full
  • General corporate purposes

Q-Line Biotech Ltd IPO Promoter Holding

Pre Issue Share Holding59.68%
Post Issue Share Holding43.69%

Q-Line Biotech Ltd IPO Subscription Status (Bidding Detail)

The Q-Line Biotech Ltd IPO is subscribed 95.3143 times on May 25, 2026 05:00:00 PM. The public issue subscribed 71.4417 times in the retail category, 123.937 times in the QIB category, and 108.2892 times in the NII category. Check Day by Day Subscription Details (Live Status)

CategoryQIBNIIRetailEmployeeTotal
Subscription (times)123.937108.289271.4417-95.3143

Q-Line Biotech Ltd IPO Prospectus

Q-Line Biotech Ltd IPO Listing Date

BSE Script
NSE Symbol
Listing In NSE - SME
ISININE1G2W01011
IPO Price₹-
Face Value-

Company Contact Information

Q-Line Biotech Ltd
298-281 Transport Nagar Kanpur#NAME?,Lucknow-226012
Phone: +91 522 2435 570
Email: compliance@qlinebiotech.com
Website: www.qlinebiotech.com

Q-Line Biotech Ltd IPO Registrar

Phone:91 22 2301 2517 / 8261
Email: newissue@purvashare.com
Website: www.purvashare.com

Q-Line Biotech Ltd IPO Lead Manager(s)

  1. Hem Securities Limited
  2. Share India Capital Services Private Limited

How to Check the Allotment Status of Q-Line Biotech Ltd IPO?

To check the IPO allotment status, follow these steps:

  • Visit the official website of the IPO registrar.
  • Navigate to the IPO Allotment Status page.
  • Select “Q-Line Biotech Ltd” from the list of available IPOs.
  • Enter any one of these - PAN Number, Application Number, DP/Client ID.
  • Click on Submit to view your allotment status.
  • Alternatively, you can also check the allotment status on the stock exchange websites such as NSE or BSE.
  • About Q-Line Biotech Ltd IPO

    Q-Line Biotech Limited was originally incorporated as 'POCT Services Private Limited' on November 10, 2010 as a Private limited company dated November 10, 2010 issued by the Assistant Registrar of Companies, Uttar Pradesh and Uttarakhand. Subsequently, the name of Company was changed to 'Q-Line Biotech Private Limited on July 23, 2021. Further, Company was converted from a private company to public company and

    IPOs for Subscription

  • FAQ